Corporates should weigh clearing OTC derivatives, experts say

04/25/2012 | Risk.net (subscription required)

Corporates have won exemptions for clearing over-the-counter derivatives, but some treasurers are not convinced that they should forgo clearing. Panelists at an industry event said companies should conduct cost-benefit analyses to determine whether central clearing of OTC derivatives is warranted.

View Full Article in:

Risk.net (subscription required)

Published in Briefs: